Intrinsic Value of S&P & Nasdaq Contact Us

Bio-Rad Laboratories, Inc. BIO NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
64/100
3/7 Pass
SharesGrow Intrinsic Value
$482.80
+65.2%
Analyst Price Target
$327.50
+12.1%

Stock Statistics — BIO

Bio-Rad Laboratories, Inc. (BIO) has a market capitalization of $7.89B and trades at $292.23. The 52-week range is 211.43-343.12.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 10.5, Earnings Per Share (EPS) of $27.87, annual revenue of $2.58B.

The stock has a beta of 1.16, operates in the Healthcare sector.

Trading Data
Current Price$292.23
52-Week Range211.43-343.12
Volume197.8K
Avg Volume (30D)297.32K
Market Cap$7.89B
Beta (1Y)1.16
Company
IPO Date1980-02-27
Employees7,700
CEONorman D. Schwartz
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS0905722072
CUSIP090572207
Income (Latest Year)
Revenue$2.58B
Gross Profit$1.34B
EBITDA$475.9M
Operating Income$270.5M
Net Income$759.9M
EPS$27.87
EPS Diluted$27.87
Shares Outstanding$27.26M
Balance Sheet (Latest Year)
Total Assets$10.58B
Current Assets$2.91B
Cash & ST Investments$1.54B
Total Liabilities$3.12B
Total Debt$1.53B
Net Debt$999.2M
Total Equity$7.45B
Debt / Equity0.21
Valuation Ratios
P/E Ratio10.5
P/S Ratio3.05
P/B Ratio1.06
EV/EBITDA (approx)16.6
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message